Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvanted influenza vaccine in the elderly
NCT00316628Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza vaccine surface antigen adjuvanted with MF59 in influenza, sponsored by Novartis. Started Jun 2005; status: completed.
02
Drugs
Influenza vaccine surface antigen adjuvanted with MF59
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00316628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316628.